Aijing Li

机构：Beijing University of Chinese Medicine, Chinese Academy of Sciences, Xinjiang Institute of Ecology and Geography, East China University of Technology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Ministry of Education, Research Center for Eco-Environmental Sciences, University of Chinese Academy of Sciences, Northwest Institute of Plateau Biology

发表论文 65 篇 · 总被引 1041 次 · h-index 17

代表论文

• Associations of Bisphenols Exposure and Hyperuricemia Based on Human Investigation and Animal Experiments (2024 · Environmental Science & Technology · 被引 22)
• Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects (2024 · Pharmacological Research · 被引 10)
• Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study (2024 · Diabetology & Metabolic Syndrome · 被引 10)
• Unveiling the metabolic fate of drugs through metabolic reaction-based molecular networking (2025 · Acta Pharmaceutica Sinica B · 被引 9)
• Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials (2025 · Frontiers in Pharmacology · 被引 7)
• Efficient SpineUNetX for X-ray: A spine segmentation network based on ConvNeXt and UNet (2024 · Journal of Visual Communication and Image Representation · 被引 7)